Akoya Biosciences Inc
Akoya Biosciences Inc (AKYA) is known on NASDAQ, but Bullrun does not have financial statement history attached to this listing yet.
Key Metrics
- TickerAKYA
- ExchangeNASDAQ
- CurrencyUSD
- Financial periodQ1 2025
- RevenueUSD 16.64M
- Net income-USD 15.65M
- Free cash flow-USD 7.42M
- Gross margin59.3%